Martingale Asset Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$771K Buy
78,800
+9,699
+14% +$95.8K 0.02% 581
2026
Q1
$672K Buy
69,101
+5,648
+9% +$51.8K 0.02% 585
2025
Q4
$606K Buy
+63,453
New +$646K 0.02% 571
2023
Q4
Sell
-12,415
Closed -$599K 837
2023
Q3
$599K Buy
12,415
+1,097
+10% +$65.2K 0.01% 567
2023
Q2
$773K Buy
+11,318
New +$730K 0.02% 520
2020
Q4
Sell
-44,635
Closed -$446K 1015
2020
Q3
$446K Sell
44,635
-60,700
-58% -$730K 0.01% 841
2020
Q2
$1.1M Buy
+105,335
New +$1.17M 0.01% 711
2015
Q2
Sell
-7,301
Closed -$279K 895
2015
Q1
$279K Buy
+7,301
New +$187K 0.01% 791

Other funds holding PRTA

Martingale Asset Management's PRTA Position: Q2 2026 in Review

Martingale Asset Management increased its Prothena Corp (PRTA) stake by 14% in Q2 2026, buying an estimated $95.8K and bringing the position to 78,800 shares worth $771K. The position accounts for 0.02% of the portfolio, ranked #581.

Martingale Asset Management first reported a position in PRTA in Q1 2015 and has held it in 8 quarters since. The position peaked at $1.1M in Q2 2020. 187 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Martingale Asset Management held 78,800 shares of Prothena Corp worth $771K as of Q2 2026.
  • Martingale Asset Management bought 9,699 Prothena Corp shares in Q2 2026, an estimated $95.8K.
  • Prothena Corp made up 0.02% of Martingale Asset Management's portfolio in Q2 2026, its #581 holding.
  • Martingale Asset Management first reported a position in Prothena Corp in Q1 2015 and has held it in 8 quarters since.
  • Martingale Asset Management's Prothena Corp position peaked at $1.1M in Q2 2020.
  • 187 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.